Quick Answer
ACADIA PHARMACEUTICALS INC reported Operating Income of $104.81 million for fiscal year 2025.
ACADIA PHARMACEUTICALS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $104.81M | -54.6% |
| 2024 | $230.79M | +414.5% |
| 2023 | -$73.38M | +67.2% |
| 2022 | -$223.60M | -31.2% |
| 2021 | -$170.44M | +40.5% |
| 2020 | -$286.59M | -16.2% |
| 2019 | -$246.54M | +0.4% |
| 2018 | -$247.44M | +15.4% |
| 2017 | -$292.41M | -7.2% |
| 2016 | -$272.81M | -65.7% |
| 2015 | -$164.61M | -76.6% |
| 2014 | -$93.23M | -143.4% |
| 2013 | -$38.30M | -83.4% |
| 2012 | -$20.89M | +8.6% |
| 2011 | -$22.85M | -251.4% |
| 2010 | $15.09M | +133.2% |
| 2009 | -$45.47M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $35.76M | +13.0% | +10.4% |
| June 30, 2025 | $32.37M | +6.4% | +67.8% |
| March 31, 2025 | $19.29M | +26.8% | -39.0% |
| September 30, 2024 | $31.64M | +154.8% | +4.0% |
| June 30, 2024 | $30.44M | +902.2% | +100.1% |
| March 31, 2024 | $15.21M | +128.4% | +126.3% |
| September 30, 2023 | -$57.78M | -87.2% | -2002.4% |
| June 30, 2023 | $3.04M | +109.0% | +105.7% |
- ACADIA PHARMACEUTICALS INC showed a decrease of -54.6% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, ACADIA PHARMACEUTICALS INC’s operating income has grown by 330.5% (from -$45.47 million to $104.81 million).
- The most recent figure is from ACADIA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: